Correlation Between Pharvaris and CEL SCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and CEL SCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and CEL SCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and CEL SCI Corp, you can compare the effects of market volatilities on Pharvaris and CEL SCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of CEL SCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and CEL SCI.

Diversification Opportunities for Pharvaris and CEL SCI

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pharvaris and CEL is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and CEL SCI Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CEL SCI Corp and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with CEL SCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CEL SCI Corp has no effect on the direction of Pharvaris i.e., Pharvaris and CEL SCI go up and down completely randomly.

Pair Corralation between Pharvaris and CEL SCI

Given the investment horizon of 90 days Pharvaris BV is expected to generate 0.85 times more return on investment than CEL SCI. However, Pharvaris BV is 1.18 times less risky than CEL SCI. It trades about -0.04 of its potential returns per unit of risk. CEL SCI Corp is currently generating about -0.29 per unit of risk. If you would invest  2,375  in Pharvaris BV on August 30, 2024 and sell it today you would lose (139.00) from holding Pharvaris BV or give up 5.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Pharvaris BV  vs.  CEL SCI Corp

 Performance 
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.
CEL SCI Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CEL SCI Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pharvaris and CEL SCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharvaris and CEL SCI

The main advantage of trading using opposite Pharvaris and CEL SCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, CEL SCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEL SCI will offset losses from the drop in CEL SCI's long position.
The idea behind Pharvaris BV and CEL SCI Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Money Managers
Screen money managers from public funds and ETFs managed around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites